CADRENAL THERAPEUTICS INC (CVKD) Stock Analyst Ratings
USA - NASDAQ:CVKD - US1276362076 - Common Stock
11.61 USD
-0.04 (-0.34%)
ChartMill assigns a Buy % Consensus number of 83% to CVKD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.38. This target is 213.35% above the current price.
CVKD was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CVKD.
In the previous month the buy percentage consensus was at a similar level.
CVKD was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-18 | Noble Capital Markets | Initiate | Outperform |
| 2023-11-20 | HC Wainwright & Co. | Initiate | Buy |
CADRENAL THERAPEUTICS INC / CVKD FAQ
What is the average price target for CADRENAL THERAPEUTICS INC (CVKD) stock?
8 analysts have analysed CVKD and the average price target is 36.38 USD. This implies a price increase of 213.35% is expected in the next year compared to the current price of 11.61.
Can you provide the consensus rating for CADRENAL THERAPEUTICS INC stock?
The consensus rating for CADRENAL THERAPEUTICS INC (CVKD) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CVKD stock?
The number of analysts covering CADRENAL THERAPEUTICS INC (CVKD) is 8.